Monday, January 24, 2022

FDA curbs use of antibody drugs sidelined by omicronFDA curbs use of antibody drugs sidelined by omicronFDA curbs use of antibody drugs sidelined by omicron

FDA curbs use of antibody drugs sidelined by omicron

The FDA said it was revoking emergency authorization for both antibody drugs Regeneron and Eli Lilly, which were purchased by the federal government and given to millions of Americans with COVID-19. 



from Section Page News - Modern Healthcare https://ift.tt/3Aszwy7

No comments:

Post a Comment